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The hemostatic system comprises platelet aggregation, coagulation and fibrinolysis and
is a host defense mechanism that protects the integrity of the vascular system after
tissue injury. During bacterial infections, the coagulation system cooperates with the
inflammatory system to eliminate the invading pathogens. However, pathogenic bacteria
have frequently evolved mechanisms to exploit the hemostatic system components for
their own benefit. Streptococcus pyogenes, also known as Group A Streptococcus,
provides a remarkable example of the extraordinary capacity of pathogens to exploit the
host hemostatic system to support microbial survival and dissemination. The coagulation
cascade comprises the contact system (also known as the intrinsic pathway) and the
tissue factor pathway (also known as the extrinsic pathway), both leading to fibrin
formation. During the early phase of S. pyogenes infection, the activation of the
contact system eventually leads to bacterial entrapment within a fibrin clot, where
S. pyogenes is immobilized and killed. However, entrapped S. pyogenes can circumvent
the antimicrobial effect of the clot by sequestering host plasminogen on the bacterial
cell surface that, after conversion into its active proteolytic form, plasmin, degrades the
fibrin network and facilitates the liberation of S. pyogenes from the clot. Furthermore, the
surface-localized fibrinolytic activity also cleaves a variety of extracellular matrix proteins,
thereby enabling S. pyogenes to migrate across barriers and disseminate within the host.
This review summarizes the knowledge gained during the last two decades on the role
of coagulation/fibrinolysis in host defense against S. pyogenes as well as the strategies
developed by this pathogen to evade and exploit these host mechanisms for its own
benefit.
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ACTIVATION OF THE CONTACT SYSTEM BY S. PYOGENES
The intrinsic pathway of coagulation, also known as
kallikrein/kinin system or contact system consists of four
components; the serine proteinases factor XI (FXI) and factor
XII (FXII), the plasma kallikrein (PK), and the non-enzymatic
cofactor, high molecular weight kininogen (HK) (Colman and
Schmaier, 1997) (Figure 1). Under physiological conditions,
these factors circulate as zymogens in the bloodstream or
are assembled on the surface of various cell types including
endothelial cells, platelets, and polymorphonuclear neutrophils
(Colman and Schmaier, 1997). Despite intensive research, the
function of the contact system remains enigmatic. A major
role of the contact system in the initiation of the coagulation
pathway has been questioned based on the absence of bleeding
disorders in individuals with hereditary deficiency on FXII
(Zeerleder et al., 1999). This is further supported by the normal
bleeding phenotype exhibited by FXII-deficient mice (Renné
et al., 2005). Interestingly, FXII deficiency in mice was associated
with a profound defect in the formation and stabilization of
platelet-rich thrombi (Renné et al., 2005). Thus, it was proposed
that activation of the extrinsic pathway of coagulation in response
to vascular injury would initiate the thrombus formation, thereby
providing a surface for assembly of the contact system that would
further support thrombus development and stabilization (Renné
et al., 2005, 2012). A role of the contact system in immunity and
inflammation has also been suggested (Frick et al., 2007; Renné,
2012).
Activation of the contact system is triggered upon binding of
FXII to negatively charged surfaces, such as dextran sulfate or
kaolin as well as to several biological activators including DNA,
RNA, and collagen (reviewed by Maas et al., 2011). Contact fac-
tors can also become activated after binding to bacterial surfaces
(reviewed by Nickel and Renné, 2012). Thus, contact factors have
been reported to bind to the surface of gram-negative (Herwald
et al., 1998; Holm et al., 2011; Murphy et al., 2011; Rapala-
Kozik et al., 2011) as well as gram-positive (Ben Nasr et al.,
1996, 1997) bacteria. In the particular case of S. pyogenes, FXII
undergoes autoactivation (FXIIa) after binding to the bacterial
surface. Subsequently, FXIIa activates PK and FXI, also anchored
to the bacterial surface via HK bound to the streptococcal M
protein (Ben Nasr et al., 1995) (Figure 2). Activation of FXI
triggers the intrinsic pathway of coagulation leading to the for-
mation of thrombin and of a fibrin clot (Figure 2). On the other
hand, activation of PK by FXIIa induces the cleavage of HK
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FIGURE 1 | Schematic representation of the coagulation cascade and the
fibrinolytic system. The coagulation cascade (blue arrows) can be activated
during hemostasis via the intrinsic pathway (contact system; red arrows) or the
extrinsic pathway (gray arrows) that ultimately converge on the common
pathway of coagulation. Both pathways lead to the activation of factor X and
subsequently of thrombin, which is required for the conversion of fibrinogen
into fibrin and for activation of factor XIII. The fibrin clot is cross-linked and
stabilized by factor XIII. Fibrinolysis (green arrows) is activated at the same time
that the coagulation system but operates more slowly and is important for the
regulation of hemostasis. During fibrinolysis, plasminogen is converted into
plasmin that degrades the fibrin network. Coagulation factors are indicatedwith
“F” followed by a roman numeral, an additional “a” denotes the activated form;
HK, high molecular weight kininogen; uPA, urokinase plasminogen activator;
tPA, tissue plasminogen activator.
FIGURE 2 | Schematic representation of contact activation on the
surface of S. pyogenes. Assembly of coagulation factors on the surface of
S. pyogenes leads to an autoactivation of factor XII (FXIIa) that, in turn,
activates factor XI (FXI) and plasma kallikrein (PK), both anchored to the
bacterial surface via high molecular weight kininogen (HK) bound to the
streptococcal M protein. Activated FXI triggers the intrinsic pathway of
coagulation while PK induces the cleavage of HK resulting in the generation
of bradykinin (BK). HK immobilized on the bacterial surface can be also
cleaved by the streptococcal cysteine proteinase (SCP).
and the generation of the vasoactive and proinflammatory pep-
tide bradykinin (BK) (Figure 2). Furthermore, the streptococcal
cysteine proteinase SCP has been also identified as one of the
bacterial factors involved in the cleavage of HK without requir-
ing previous activation of PK (Herwald et al., 1996) (Figure 2).
Based on these observations, it was proposed that the recruit-
ment of high amounts of HK by the M protein on the surface
of S. pyogenes could lead to a local burst of kinins by the action of
SCP. This would result in increased vascular permeability leading
to exudation of high amounts of plasma proteins and nutrients
into the site of infection (Herwald et al., 1996). Extravasation of
massive fluid from the intravascular compartment out into the
tissues can induce a drop in blood pressure that can contribute to
the development of sepsis and septic shock, which are the most
severe clinical outcomes of S. pyogenes infections (Henningham
et al., 2012). Further evidence supporting an activation of the
contact system during invasive streptococcal infection was pro-
vided by the prolonged activated partial thromboplastin time
(aPTT) observed in mice experimentally infected with S. pyo-
genes (Sriskandan et al., 2000). Prolonged aPTTs have also been
detected in patients with septic shock (Smith-Erichsen et al.,
1982) and extensive pulmonary hemorrhage has been observed
in post-mortem examination of lungs isolated from patients that
succumbed after fulminant S. pyogenes infection (Ooe et al.,
1999).
S. pyogenes M1 protein as well as other bacterial virulence
factors have been reported to stimulate the production of pro-
coagulant microversicles, which are small particles released from
the cell membrane of activated or apoptotic cells (Piccin et al.,
2007) and from peripheral blood mononuclear cells (Oehmcke
et al., 2012). S. pyogenes has been shown to induce apoptosis
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in several host cell types such as neutrophils, keratinocytes and
epithelial cells through different virulence factors and this has
been suggested to play a role in the infectious process (for review
see Ulett and Adderson, 2006). Activation of the contact system
on these microvesicles was shown to contribute to clot stabiliza-
tion and stimulation of inflammatory responses by the generation
of BK (Oehmcke et al., 2012). Pro-coagulant monocyte-derived
microvesicles were also found in plasma from septic patients
(Oehmcke et al., 2012).
In summary, experimental animal studies and clinical data
indicate a link between activation of the contact system and
invasive S. pyogenes infections. Therefore, interfering with the
activation of the contact system has been considered as thera-
peutic intervention to improve the outcome of severe invasive
S. pyogenes infection. As proof of principle, treatment with a pep-
tide (HKH20) derived from the region of human HK involved
in the binding to negative charged surfaces (Hasan et al., 1995),
was shown to block the assembly and activation of the con-
tact system and to prevent lung bleedings and early mortality
of S. pyogenes-infected mice when administered in combination
with clindamycin (Oehmcke et al., 2009a).
THE ROLE OF THE COAGULATION SYSTEM IN INNATE HOST
DEFENSE AGAINST S. PYOGENES
It has been proposed that the vertebrate coagulation system is
evolutionarily a by-product of the innate immune system, with
the blood clotting factors having diverged from the complement
system (Krem and Di Cera, 2002). In this regard, there is a
growing body of evidence suggesting the contribution of the coag-
ulation system to host defense against invading pathogens. The
role of the coagulation system in early innate immune defenses
is most prominent in S. pyogenes infections. For example, the
D3 domain of HK, has been reported to exert direct antimi-
crobial activity against S. pyogenes (Frick et al., 2006). HK is
organized into six structural domains: domains 1–3 (D1–D3) are
related to cystatin, D4 contains the BK peptide, D5mediates bind-
ing to negatively charged surfaces, and the carboxyl-terminal D6
contains a zymogen binding sequence for FXI and prekallikrein
which, with D5, accounts for its cofactor activity (Colman and
Schmaier, 1997). Although intact HK does not have anti-bacterial
effect, the D3 fragments released after enzymatic cleavage of
HK by for example neutrophils elastase (Vogel et al., 1988),
possess strong bactericidal activity (Frick et al., 2006). Thus, it
was proposed that, after assembly and activation of the con-
tact system on bacterial surfaces, HK can be cleaved by elastase
released by activated neutrophils, resulting in the simultaneous
release of antibacterial D3 fragments and BK that will further
promote inflammation and plasma leakage (Frick et al., 2006).
Other components of the contact system such as the domain
D5 of HK have been also reported to exert antimicrobial effect
(Nordahl et al., 2005).
Contact activation leads to the induction of the entire coagu-
lation cascade and there is evidence that entrapment of microor-
ganisms after clot formation may hamper their dissemination
from the local site of infection. This mechanism appears to be
highly conserved during evolution from invertebrates to humans
(Rotstein, 1992; Sun et al., 2004; Matsuda et al., 2007; Loof et al.,
2011a) and it has been designated as “immunothrombosis” by
Engelmann and Massberg (2013). The ultimate goal of the coag-
ulation pathway is to produce thrombin, which is generated from
its inactive precursor prothrombin by the prothrombinase com-
plex formed by FXa and its co-factor FVa. The main functions
of thrombin are the conversion of fibrinogen to fibrin as well
as the activation of coagulation FXIII. Fibrin strands are then
cross-linked by activated FXIII (FXIIIa) to form a stable blood
clot (Figure 1). During the process of thrombin generation in
blood, part of the early-generated thrombin feeds back on the cas-
cade system to activate FV and FVIII (Figure 1), thus promoting
further thrombin generation (Brummel et al., 2002). Thrombin
generation takes place on the surface of activated platelets that
form the primary hemostatic plug (Brass, 2003). The relevance of
thrombin generation in antimicrobial host defense against S. pyo-
genes was examined by Sun and co-workers using mice with
deficiency of FV in either the plasma or the platelet compartment
(Sun et al., 2009). They reported that reduction of FV in either
pool resulted in increased mortality of mice after subcutaneous
inoculation of S. pyogenes, thus supporting a role of thrombin
generation in host defense against this pathogen (Sun et al., 2009).
The authors hypothesized that local fibrin depositionmediated by
both the platelet and plasma FV pools could reduce the survival
and dissemination of S. pyogenes by limiting vascular invasion and
hematogenous spread (Sun et al., 2009). The capacity of the fib-
rin clot to immobilize and kill S. pyogenes was first demonstrated
by Shannon et al. (2010). They also demonstrated that histidine-
rich glycoprotein (HRP), an abundant plasma protein, played a
critical role in this defense mechanism (Shannon et al., 2010).
Thus, clots formed in HRG-deficient plasma were less effective
than those formed in normal plasma at entrapping and killing
S. pyogenes (Shannon et al., 2010). Furthermore, HRG-deficient
mice exhibited increased susceptibility to S. pyogenes infection
than wild-type mice, a phenotype that was reverted after supple-
menting the HRG-deficient mice with purified HRG (Shannon
et al., 2010). FXIII was also shown to be an important factor
for the entrapment of different bacterial pathogens within clots
since clots generated in plasma from FXIII-deficient individu-
als lost the capacity to immobilize bacteria (Wang et al., 2010).
Therefore, FXIII-mediated entrapment of pathogens within a
fibrin clot seems to be a general immune defense mechanism
against bacterial pathogens (Wang et al., 2010). It has also been
reported that FXIII mediates cross-linking of bacterial surface
structures, such as the M1 protein of S. pyogenes, to fibrin fibers
within the clot, where the microorganisms are subsequently killed
by the induction of plasma-derived antimicrobial activity (Loof
et al., 2011b). The electron microscopy photographs depicted
in Figure 3 show the FXIII-mediated entrapment of S. pyogenes
bacteria of strain AP1 (serotype M1) in a fibrin clot. A large
amount of bacteria were enwoven within the fibrin network when
the clot was generated in normal human plasma (Figure 3A)
whereas only a few bacteria are found loosely associated with
the clot when FXIII-deficient plasma was used (Figure 3B). It
was also reported that mice deficient in FXIII exhibited higher
levels of local inflammation than wild-type mice after sub-
cutaneous inoculation with S. pyogenes (Loof et al., 2011b).
Furthermore, streptococci were found confined within the fibrin
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FIGURE 3 | Entrapment of S. pyogenes within a fibrin clot is mediated
by Factor XIII. Scanning electron micrograph of S. pyogenes bacteria of
strain AP1 (M1 serotype) within a clot generated in normal human plasma
(A) or in Factor XIII-deficient human plasma (B). The scale bar represents
10μm.
meshwork in skin biopsies from infected wild-type mice, but
they were spread throughout the site of infection in infected
FXIII-deficient mice (Loof et al., 2011b). A similar immobi-
lization of bacteria within fibrin networks was also observed
in skin biopsies obtained from patients with severe S. pyo-
genes infections (Loof et al., 2011b). These observations under-
score the relevance of FXIII in the early control of S. pyogenes
infection.
THE ROLE OF FIBRINOGEN IN INNATE HOST DEFENSE
AGAINST S. PYOGENES
Fibrinogen is a plasma glycoprotein synthesized in the liver that
is essential for blood coagulation. In order to form a clot, sol-
uble fibrinogen must be converted into insoluble fibrin poly-
mer by thrombin (Blombäck et al., 1978). Fibrinogen has been
suggested to play an important role in host defense against
S. pyogenes by limiting both bacterial hematogenous dissem-
ination and by promoting inflammation leading to bacterial
clearance (Sun et al., 2004, 2009). Thus, it was reported that
reduction of fibrinogen levels after injection of snake venom
enhanced the mortality of S. pyogenes-infected mice (Sun et al.,
2004). Furthermore, mice deficient in the production of fib-
rinogen (Fga−/−) were also highly susceptible to S. pyogenes
(Sun et al., 2009).
The important role played by fibrinogen for confining and
neutralizing S. pyogenes during the early infection was further
demonstrated by Påhlman et al. (2013). This group showed that
the peptide fragment GHR28 released from the β-chain of fib-
rinogen after activation with thrombin exerted antimicrobial
activity against S. pyogenes organisms entrapped within a fibrin
clot (Påhlman et al., 2013). Nevertheless, binding of plasminogen
to the bacterial surface was a pre-requisite for effective bacterial
killing (Påhlman et al., 2013). Kantor and Cole described for the
first time the capacity of a S. pyogenes factor, which they named
FPF (fibrinogen precipitating factor), to precipitate human and
bovine fibrinogen (Kantor and Cole, 1959). In further exper-
iments, Kantor confirmed the identity of FPF and M protein
(Kantor, 1965). The M protein is the major virulence determi-
nant of S. pyogenes by virtue of its ability to promote the survival
of the bacterium in human blood (Fischetti, 1989; Oehmcke et al.,
2010). M protein is exposed on the surface of S. pyogenes but it
can also be released after proteolytic cleavage by cysteine pro-
teinases also secreted by S. pyogenes (Berge and Björck, 1995).
Due to its high affinity to bind fibrinogen, the release of high
amounts ofM protein during severe S. pyogenes infection can have
grave consequences for the patient. In this regard, it was demon-
strated that rapid formation of M1 protein/fibrinogen complexes
in plasma-activated neutrophils resulted in high levels of plasma
leakage, which is one of the events involved in the development of
life-threatening streptococcal septic shock (Herwald et al., 2004).
To clarify the molecular mechanism underlying the activation
of neutrophils by M1 protein/fibrinogen complexes, Macheboeuf
and colleagues determined the resolution crystal structure of an
M1 protein/fibrinogen complex (Macheboeuf et al., 2011). They
found that a conformationally dynamic coiled-coil dimer of M1
organized four fibrinogen molecules into a specific cross-like
pattern that supported the construction of a supramolecular net-
work (Macheboeuf et al., 2011). This supramolecular structure
presented high densities of integrin-binding sites required for
neutrophil activation (Macheboeuf et al., 2011). The M1 pro-
tein/fibrinogen supramolecular networks contributed to patho-
genesis since blocking M1-fibrinogen interactions was shown to
reduce S. pyogenes virulence both in vitro and in vivo (Uchiyama
et al., 2013). Fibrinogen binding to surface-exposed M protein
was also reported to confer bacterial resistance to phagocyto-
sis by inhibiting complement deposition via the classical path-
way (Carlsson et al., 2005). However, the functional effect of
M protein-fibrinogen interactions differs depending on the M
protein type. Thus, whereas binding of fibrinogen by the M5
protein inhibited complement activation (Carlsson et al., 2005),
the binding of fibrinogen to M6 protein had not effect on com-
plement deposition or resistance to phagocytosis (Horstmann
et al., 1992). The reasons for these differences remain a matter of
debate.
Fibrinogen has been also reported to serve as a docking
molecule that attaches S. pyogenes to the pro-coagulant microvesi-
cles described in a previous section (Oehmcke et al., 2013). This
interaction leads to an alteration of the bacterial surface into a
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pro-coagulative state and immobilization of S. pyogenes within
a clot (Oehmcke et al., 2013). The clots generated in the pres-
ence of pro-coagulant microvesicles have antimicrobial activity
against S. pyogenes, which could be mediated by the antimi-
crobial peptides and other immune response proteins present
in the microvesicles (Oehmcke et al., 2013). Local treatment
of S. pyogenes-infected mice with pro-coagulant microvesicles
results in reduced bacterial spreading and improved survival
of infected animals indicating that interaction of S. pyogenes
with pro-coagulant microvesicles may be an integral part of the
innate immune response to this pathogen (Oehmcke et al., 2013).
Oehmcke and colleagues also reported that fibrinogen in complex
with M1 protein can trigger polymorphonuclear neutrophils to
release extracellular traps (NETs) (Oehmcke et al., 2009b), which
are made of processed chromatin bound to granular and selected
cytoplasmic proteins (Brinkmann et al., 2004). Therefore, they
proposed that the recruitment and activation of the contact
system by NETs amplifies the innate immune response during
streptococcal infection (Oehmcke et al., 2013).
EXPLOITATION OF HOST FIBRINOLYTIC SYSTEM BY
S. PYOGENES
Fibrinolysis is the physiological process by which insoluble fibrin
clots are removed through enzymatic digestion of the cross-linked
fibrin polymers (Cesarman-Maus and Hajjar, 2005). Under phys-
iological conditions, both coagulation and fibrinolysis are strictly
regulated to assure blood fluidity while preventing blood loss
(Kolev and Machovich, 2003). Plasmin is the major fibrinolytic
protease responsible for the lysis of fibrin to produce smaller frag-
ments resulting in the degradation of fibrin clots. Furthermore,
plasmin is capable of degrading extracellular matrix proteins
and activates matrix metalloproteinases leading to tissue dam-
age (Plow et al., 1995; Monea et al., 2002). Plasmin is generated
from circulating plasma plasminogen by both tissue plasmino-
gen activator (tPA) as well as by urokinase (uPA) (Figure 1).
These activators are present at various anatomical sites such as
the vascular endothelium.
As described above, activation of the coagulation system upon
infection can lead to entrapment of S. pyogenes within the fib-
rin network, thus preventing bacterial spreading. To counteract
this entrapment, S. pyogenes has evolved strategies to induce fib-
rinolysis and to escape from the clot as depictured in Figure 4.
The fibrinolytic activity of S. pyogenes was described already in
1933 (Tillett and Garner, 1933). Garner and Tillett identified
the streptococcal factor responsible for the fibrinolytic activity
that they designated as Fibrinolysin (Garner and Tillett, 1934)
and later was renamed Streptokinase (SK) (Green, 1948). SK
produced by S. pyogenes is highly specific for human plasmino-
gen (Marcum and Kline, 1983). To overcome this limitation
and evaluated the role of SK in experimental murine infection
models, Khil et al. (2003) co-administered exogenous human
plasminogen together with S. pyogenes into mice. They reported
enhanced skin lesions areas and greater mortality in mice inoc-
ulated with wild-type S. pyogenes co-administered with human
plasminogen that in mice inoculated with SK-deficient S. pyo-
genes also in the presence of human plasminogen (Khil et al.,
FIGURE 4 | Schematic overview of the interactions between
S. pyogenes and the coagulation/fibrinolytic system during infection.
Contact system activation upon S. pyogenes infection is leading to the
induction of the entire coagulation cascade (blue arrows).
Thrombin-activated factor XIII (FXIIIa) targets surface structures of
S. pyogenes such as the M1 protein and leads to bacterial entrapment
within the fibrin network of the clot. S. pyogenes can counteract this
mechanism by inducing fibrinolysis (green arrows) through the secretion
of Streptokinase. Fibrinolysis is leading to clot degradation and therefore
enables the dissemination of S. pyogenes.
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2003). Similarly, enhanced virulence of S. pyogenes was observed
by Li et al. (1999) after pre-incubating streptococci in human
plasma but not in plasminogen-depleted plasma. The important
role of plasminogen in the pathogenesis of S. pyogenes infection
was further demonstrated using “humanized” transgenic mice
expressing human plasminogen (Sun et al., 2004). The transgenic
mice expressing human plasminogen exhibited greater suscepti-
ble to subcutaneously inoculated S. pyogenes thanmice expressing
the native murine plasminogen (Sun et al., 2004). Furthermore,
the increased susceptibility of human plasminogen transgenic
mice to S. pyogeneswas largely abrogated after deletion of SK (Sun
et al., 2004). Thus, the SK-plasminogen interaction was demon-
strated to be an important determinant of S. pyogenes invasiveness
in vivo. These authors (Sun et al., 2004) also examined the impact
on bacterial pathogenicity of recruiting plasminogen by protein
PAM, which is expressed by a subset of S. pyogenes strains asso-
ciated with skin infections (Bessen et al., 1996). PAM-expressing
streptococci acquired surface-bound plasmin that contributed to
bacterial virulence (Ringdahl et al., 1998). Human plasminogen
transgenic mice were much more susceptible to PAM-expressing
S. pyogenes than to an isogenic derivative deficient in the expres-
sion of PAM, even in the presence of SK (Sun et al., 2004).
Therefore, the ability to recruit plasminogen at the bacterial
surface provides and additional mechanism of S. pyogenes to
promote pericellular fibrinolysis and degradation of components
of extracellular matrix and subsequent tissue invasion. Based
on these observations, pharmacological disruption of SK activ-
ity has been proposed as potential therapeutic strategy to treat
severe invasive S. pyogenes infections (McArthur et al., 2012). In
this regard, a compound designated as CCG-2979, was identified
as capable to inhibit gene expression of SK through a high-
throughput, growth-based screen on a library of 55,000 small
molecules (Sun et al., 2012). Treatment with CCG-2979 enhanced
both granulocyte phagocytosis and killing of S. pyogenes in vitro
and protected mice from S. pyogenes-induced mortality (Sun
et al., 2012). A series of novel compounds analogs to CCG-2979
has been constructed by Yestrepsky et al. (2013) with improved
physico-chemical properties and potent Staphylococcus aureus
biofilm inhibitory effect. The anti-infective efficacy of these new
compounds during in vivo infection remains to be determined.
Surface-acquired plasmin activity by S. pyogenes has also
been shown to degrade host cathelicidin antimicrobial peptides
(Hollands et al., 2012). Cathelicidin peptides are important for
host defense against S. pyogenes (Nizet et al., 2001). Therefore,
the co-optation of the host protease activity represents an addi-
tional mechanism of S. pyogenes to resist the antimicrobial effect
of cathelicidins.
CONCLUDING REMARKS
The experimental evidence discussed in this review clearly
demonstrates a bi-directional relationship between the coagula-
tion/fibrinolytic system and S. pyogenes. A schematic overview
of these interactions is depictured in Figure 4. Coagulation is
important in host responses to S. pyogenes and the activation of
the contact system and local formation of fibrin prevents spread
of the invading pathogen. However, S. pyogenes is also capa-
ble to hijack the fibrinolytic system to evade this host response.
S. pyogenes exploits the host fibrinolysis not only for dismantling
the imprisoning fibrin clot but also for degrading the extracellu-
lar matrix and invade the surrounding tissue. Hence, the balance
between the antimicrobial effect of the coagulation system and
the bacterial exploitation of the host fibrinolysis is a critical
point that will determine the progression of S. pyogenes infection.
Therefore, pharmacological intervention that will balance coag-
ulation and fibrinolysis may be of benefit for the treatment of
severe S. pyogenes infection.
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